Nicotine, Marijuana Use Underreported by Plastic Surgery Patients
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- Plastic surgery patients who use marijuana also have elevated nicotine levels, according to a study published in the September issue of Plastic and Reconstructive Surgery.
Yi-Hsueh Lu, M.D., Ph.D., from Montefiore Medical Center at the Albert Einstein College of Medicine in the Bronx, New York, and colleagues sought to understand marijuana and nicotine use in plastic surgery patients. The analysis included survey results from 135 consecutive patients presenting to a single clinic seeking elective procedures.
The researchers found that 50 percent were nonusers, 19 percent were active nicotine users, 7 percent were active marijuana users, 13 percent were active users of both, and 11 percent were past users. Among marijuana users who denied nicotine use, urine analyses showed significantly elevated nicotine and cotinine levels versus nonusers (average nicotine level, 23.1 ng/mL; average cotinine level, 221.2 ng/mL). During clinical encounters, fewer than one-third of active marijuana or nicotine users reported active use. Postoperative complications did not differ by nicotine or cotinine urine levels, reported use, or other patient characteristics.
"In clinical settings, underreporting of nicotine-containing product use, including marijuana, remains a concern for unrecognized surgical risk, and affects the decision on offering elective procedures," the authors write. "Despite that, a correlation between a positive urine test result and negative surgical outcome has not been demonstrated."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip
TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...
Wearable-Derived Biorhythms Predict Complications After Appendectomy
MONDAY, July 14, 2025 -- Wearable-derived biorhythms can predict postoperative complications in children undergoing appendectomy, according to a study published online July 9 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.